- Home
- NVO vs WFC Comparison
NVO vs WFC Comparison
Compare NVO & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVO | WFC |
|---|---|---|
| Founded | 1923 | 1852 |
| Country | Denmark | United States |
| Employees | 69500 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.1B | 290.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVO | WFC |
|---|---|---|
| Price | $40.44 | $81.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 18 |
| Target Price | $51.00 | ★ $96.59 |
| AVG Volume (30 Days) | ★ 14.1M | 12.6M |
| Earning Date | 05-06-2026 | 04-14-2026 |
| Dividend Yield | ★ 3.15% | 2.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.41 |
| Revenue Next Year | $3.88 | $4.51 |
| P/E Ratio | ★ $13.60 | $14.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.12 | $63.40 |
| 52 Week High | $81.44 | $97.76 |
Technical Indicators
Market Signals| Indicator | NVO | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 60.30 | 49.97 |
| Support Level | $35.49 | $81.05 |
| Resistance Level | $50.30 | $83.99 |
| Average True Range (ATR) | 0.99 | 1.77 |
| MACD | 0.79 | 0.33 |
| Stochastic Oscillator | 86.01 | 50.78 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.1 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.